Skip to content
10-Q

Quarterly Report

TriVascular Technologies, Inc.

0001564590-15-003431

← back to feed
Filed
May 6, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · Apr 30, 2015 20.5M sh
Capex Q1 2015 · Mar 31, 2015 $51K
Capex Q1 2015 · Mar 31, 2014 $10K
Cash And Equivalents Q1 2015 · Mar 31, 2015 $20.12M
Cash And Equivalents Q1 2015 · Dec 31, 2014 $32.9M
Cash And Equivalents Q1 2015 · Mar 31, 2014 $31.41M
Cash And Equivalents Q1 2015 · Dec 31, 2013 $38.11M
Stockholders Equity Q1 2015 · Mar 31, 2015 $25.33M
Stockholders Equity Q1 2015 · Dec 31, 2014 $39.57M
Current Liabilities Q1 2015 · Mar 31, 2015 $10.5M
Current Liabilities Q1 2015 · Dec 31, 2014 $10.33M
Total Liabilities Q1 2015 · Mar 31, 2015 $69.6M
Total Liabilities Q1 2015 · Dec 31, 2014 $68.96M
Current Assets Q1 2015 · Mar 31, 2015 $83.55M
Current Assets Q1 2015 · Dec 31, 2014 $97.05M
Total Assets Q1 2015 · Mar 31, 2015 $94.93M
Total Assets Q1 2015 · Dec 31, 2014 $108.53M
Sga Expense Q1 2015 · Mar 31, 2015 $14.17M
Sga Expense Q1 2015 · Mar 31, 2014 $12.19M
Rd Expense Q1 2015 · Mar 31, 2015 $4.05M
Rd Expense Q1 2015 · Mar 31, 2014 $3.81M
Net Income Q1 2015 · Mar 31, 2015 −$15.64M
Net Income Q1 2015 · Mar 31, 2014 −$14.42M
Operating Income Q1 2015 · Mar 31, 2015 −$13.55M
Operating Income Q1 2015 · Mar 31, 2014 −$12.63M
Gross Profit Q1 2015 · Mar 31, 2015 $4.67M
Gross Profit Q1 2015 · Mar 31, 2014 $3.37M
Cost Of Revenue Q1 2015 · Mar 31, 2015 $3.36M
Cost Of Revenue Q1 2015 · Mar 31, 2014 $3.67M